Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debasish Sahoo

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Discover Oncology|June 21, 2026
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)Jagdish Prasad Meena, Debasish Sahoo, Harshita Makkar, et al.
The Lancet Regional Health. Southeast Asia|February 16, 2026
Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016-2024)Rachna Seth, Gauri Kapoor, Nirmalya Roy Moulik, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Discover Oncology|June 21, 2026
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)Jagdish Prasad Meena, Debasish Sahoo, Harshita Makkar, et al.
The Lancet Regional Health. Southeast Asia|February 16, 2026
Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016-2024)Rachna Seth, Gauri Kapoor, Nirmalya Roy Moulik, et al.
Pageof 3